In patient samples diagnosed with pleural Malignant Mesothelioma (MM), expression levels of LDH-A and GLUT-1 were studied both at baseline and after platinum-based-chemotherapy. The gene discussed is SLC2A1; the disease is malignant pleural mesothelioma.